No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumour load

Histopathology

Volumn 59, Issue 2, 2011, Pages 318-326

  Bogenrieder, Thomas ^a,b   van Dijk, Marijke R ^a   Blokx, Willeke A M ^c   Ramrath, Katrin ^d   Seldenrijk, Kees ^e   Stolz, Wilhelm ^d   Van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GLAXOSMITHKLINE   (Germany)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Klinikum Schwabing   (Germany)

^e ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Lymph node metastases; Lymph node staging; Melanoma; S classification; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; BRESLOW THICKNESS; CANCER DIAGNOSIS; CANCER PATIENT; DISEASE SEVERITY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORPHOMETRICS; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; THICKNESS; TUMOR VOLUME;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 80052249356     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03931.x     Document Type: Article

References (38)

1. Cascinelli N, Belli F, Santinami M et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann. Surg. Oncol. 2000; 7; 469-474.
2. Houghton A, Coit D, Bloomer W et al. NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 1998; 12; 153-177.
3. Scolyer RA, Murali R, Satzger I, Thompson JF. The detection and significance of melanoma micrometastases in sentinel nodes. Surg. Oncol. 2008; 17; 165-174.
4. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 1992; 127; 392-399.
5. McMasters KM, Reintgen DS, Ross MI et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J. Clin. Oncol. 2001; 19; 2851-2855.
6. Balch CM, Soong S, Ross MI et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0mm). Intergroup Melanoma Surgical Trial. Ann. Surg. Oncol. 2000; 7; 87-97.
7. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998; 351; 793-796.
8. Sabel MS, Gibbs JF, Cheney R, McKinley BP, Lee JS, Kraybill WG. Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute-designated cancer center. Surgery 2000; 128; 556-563.
9. Wagner JD, Gordon MS, Chuang TY et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2000; 89; 453-462.
10. Gershenwald JE, Thompson W, Mansfield PF et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J. Clin. Oncol. 1999; 17; 976-983.
11. McMasters KM, Wong SL, Edwards MJ et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann. Surg. Oncol. 2002; 9; 137-141.
12. Krag DN, Meijer SJ, Weaver DL et al. Minimal-access surgery for staging of malignant melanoma. Arch. Surg. 1995; 130; 654-658.
13. Thompson JF, McCarthy WH, Bosch CM et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995; 5; 255-260.
14. Starz H, Balda BR, Kramer KU, Buchels H, Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91; 2110-2121.
15. Gershenwald JE, Andtbacka RH, Prieto VG et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J. Clin. Oncol. 2008; 26; 4296-4303.
16. Vuylsteke RJ, Borgstein PJ, van Leeuwen PA et al. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma. Ann. Surg. Oncol. 2005; 12; 440-448.
17. Vuylsteke RJ, van Leeuwen PA, Statius Muller MG, Gietema HA, Kragt DR, Meijer S. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J. Clin. Oncol. 2003; 21; 1057-1065.
18. van Akkooi AC, de Wilt JH, Verhoef C et al. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur. J. Cancer 2006; 42; 372-380.
19. Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J. Clin. Oncol. 2004; 22; 3345-3349.
20. Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J. Clin. Oncol. 2004; 22; 3677-3684.
21. Wagner JD, Schauwecker D, Davidson D et al. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J. Clin. Oncol. 1999; 17; 1508-1515.
22. Starz H. Pathology of the sentinel lymph node in melanoma. Semin. Oncol. 2004; 31; 357-362.
23. Reeves ME, Delgado R, Busam KJ, Brady MS, Coit DG. Prediction of nonsentinel lymph node status in melanoma. Ann. Surg. Oncol. 2003; 10; 27-31.
24. Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod. Pathol. 2004; 17; 747-755.
25. Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 2001; 19; 3635-3648.
26. van Diest PJ, Torrenga H, Meijer S, Meijer CJ. Pathologic analysis of sentinel lymph nodes. Semin. Surg. Oncol. 2001; 20; 238-245.
27. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann. Surg. Oncol. 2004; 11(Suppl. 3); 162S-168S.
28. Gershenwald JE, Colome MI, Lee JE et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J. Clin. Oncol. 1998; 16; 2253-2260.
29. Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer 2001; 91; 2401-2408.
30. Cochran AJ, Huang RR, Guo J, Wen DR. Current practice and future directions in pathology and laboratory evaluation of the sentinel node. Ann. Surg. Oncol. 2001; 8(Suppl. 9); 13S-17S.
31. Morton DL, Cochran AJ, Thompson JF et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann. Surg. 2005; 242; 302-311.
32. Cascinelli N, Clemente C, Bifulco C et al. Do patients with tumor-positive sentinel nodes constitute a homogeneous group? Ann. Surg. Oncol. 2001; 8(Suppl. 9); 35S-37S.
33. Wagner JD, Davidson D, Coleman JJ III et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann. Surg. Oncol. 1999; 6; 398-404.
34. Carlson GW, Murray DR, Lyles RH, Staley CA, Hestley A, Cohen C. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann. Surg. Oncol. 2003; 10; 575-581.
35. Van Akkooi AC, Spatz A, Eggermont AM, Mihm M, Cook MG. Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden. Eur. J. Cancer 2009; 45; 2736-2742.
36. Scolyer RA, Li LX, McCarthy SW et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am. J. Clin. Pathol. 2004; 122; 532-539.
37. Wrightson WR, Wong SL, Edwards MJ et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of nonsentinel nodes following completion lymphadenectomy for melanoma. J. Surg. Res. 2001; 98; 47-51.
38. van Deurzen CH, de BM, Monninkhof EM et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J. Natl. Cancer Inst. 2008; 100; 1574-1580.